{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:10:32Z","timestamp":1767928232579,"version":"3.49.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"abstract":"<jats:p>\n                    To analyze the effects of drug treatments and types of drugs on pregnancy outcomes in pregnant women at different gestational ages. The records of 526 pregnant women from our hospital from September 2018 to January 2024 were analyzed retrospectively. Women were categorized into 3 groups: normal delivery, artificial abortion, and spontaneous abortion. Data on maternal age, gestational age, smoking, drinking, radiation, medication timing, and types were collected and compared. Pearson correlation analysis assessed relationships between pregnancy outcomes, gestational age at medication, and medication types. After comparing multiple potential influencing factors, it was found that smoking history, timing of medication, and the use of antitussive and phlegm-reducing medications differed significantly among the different pregnancy outcome groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Multiple regression analysis showed that the gestational age at which pregnant women took medication was a significant positive influencing factor for adverse pregnancy outcomes, specifically artificial abortion (Coefficient\u2005=\u20050.210,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.002). In addition, the use of antitussive and phlegm-reducing medications had a positive directional influence on adverse pregnancy outcomes, specifically spontaneous abortion (Coefficient\u2005=\u20050.294,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.016). Further analysis showed that as the gestational age at the time of medication increased, the normal delivery rate initially increased and then decreased. The rate of artificial abortion first increased and then stabilized, while the spontaneous abortion rate showed minimal fluctuation. The use of medications by pregnant women and the duration of pregnancy significantly impact induced abortion rates. Cough and mucus-reducing medications can lead to miscarriage, while other drugs in early pregnancy generally do not affect outcomes. Antitussive and mucus-reducing drugs specifically increase the risk of spontaneous abortion. Raising awareness about proper medication use and conducting research on this topic is crucial for enhancing prenatal and postnatal care, reducing induced abortions, and promoting population growth.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000041646","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:01:37Z","timestamp":1742310097000},"page":"e41646","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effects of drug treatments and types of drugs used by pregnant women at different gestational ages on pregnancy outcomes: A retrospective study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9151-8634","authenticated-orcid":false,"given":"Yuan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Jianyang Maternal and Child Health Hospital, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoneng","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Jianyang Chinese Medicine Hospital, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Jianyang Maternal and Child Health Hospital, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Jianyang Maternal and Child Health Hospital, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260108","doi-asserted-by":"crossref","first-page":"e0195101","DOI":"10.1371\/journal.pone.0195101","article-title":"Medications and pregnancy: the role of community pharmacists \u2013 a descriptive study.","volume":"13","author":"Leung","year":"2018","journal-title":"PLoS One"},{"key":"R2-20260108","doi-asserted-by":"crossref","first-page":"1111601","DOI":"10.3389\/fphar.2023.1111601","article-title":"Drug exposure during pregnancy: current understanding and approaches to measure maternal-fetal drug exposure.","volume":"14","author":"Hudson","year":"2023","journal-title":"Front Pharmacol"},{"key":"R3-20260108","doi-asserted-by":"crossref","first-page":"e054122","DOI":"10.1136\/bmjopen-2021-054122","article-title":"Over-the-counter provision of emergency contraceptive pills: a systematic review.","volume":"12","author":"Atkins","year":"2022","journal-title":"BMJ Open"},{"key":"R4-20260108","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jaip.2022.03.005","article-title":"Exposure to allergen-specific immunotherapy in pregnancy and risk of congenital malformations and other adverse pregnancy outcomes.","volume":"10","author":"Mitselou","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R5-20260108","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12884-018-1728-y","article-title":"Antiepileptic drug exposure in pregnancy and pregnancy outcome from national drug usage data.","volume":"18","author":"Richards","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"R6-20260108","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/2042098611433192","article-title":"Antiepileptic drugs in women with epilepsy during pregnancy.","volume":"3","author":"Gedzelman","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"R7-20260108","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2174\/138920012800840374","article-title":"Physiologically-based pharmacokinetic (PBPK) models for assessing the kinetics of xenobiotics during pregnancy: achievements and shortcomings.","volume":"13","author":"Lu","year":"2012","journal-title":"Curr Drug Metab"},{"key":"R8-20260108","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41583-023-00733-6","article-title":"The transition to motherhood: linking hormones, brain and behaviour.","volume":"24","author":"Servin-Barthet","year":"2023","journal-title":"Nat Rev Neurosci"},{"key":"R9-20260108","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40264-021-01077-9","article-title":"Risk of pregnancy termination and congenital anomalies after domperidone exposure: a study in the EFEMERIS database.","volume":"44","author":"Araujo","year":"2021","journal-title":"Drug Saf"},{"key":"R10-20260108","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejogrb.2021.12.001","article-title":"Favipiravir exposure and pregnancy outcome of COVID-19 patients.","volume":"268","author":"Tirmik\u00e7io\u011flu","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R11-20260108","doi-asserted-by":"crossref","first-page":"e0219424","DOI":"10.1371\/journal.pone.0219424","article-title":"Community pharmacist counseling in early pregnancy-results from the SafeStart feasibility study.","volume":"14","author":"Truong","year":"2019","journal-title":"PLoS One"},{"key":"R12-20260108","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.293.1.54","article-title":"Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial.","volume":"293","author":"Raine","year":"2005","journal-title":"JAMA"},{"key":"R13-20260108","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11096-020-01203-0","article-title":"Assessment of community pharmacy management towards self-medication requests of tetracyclines for pregnant women: a simulated client study in Upper Egypt.","volume":"43","author":"Tawfik","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"R14-20260108","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4193\/Rhino15.228","article-title":"Management of rhinosinusitis during pregnancy: systematic review and expert panel recommendations.","volume":"54","author":"Lal","year":"2016","journal-title":"Rhinology"},{"key":"R15-20260108","doi-asserted-by":"crossref","first-page":"e0277623","DOI":"10.1371\/journal.pone.0277623","article-title":"Patterns of antiemetic medication use during pregnancy: a multi-country retrospective cohort study.","volume":"17","author":"Fisher","year":"2022","journal-title":"PLoS One"},{"key":"R16-20260108","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11096-020-01033-0","article-title":"Community pharmacy sales of non-prescribed antibiotics in Riyadh, Saudi Arabia: a simulated patient study.","volume":"42","author":"Al-Tannir","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"R17-20260108","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jaip.2020.02.017","article-title":"Desloratadine use during pregnancy and risk of adverse fetal outcomes: a nationwide cohort study.","volume":"8","author":"Andersson","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R18-20260108","first-page":"483","article-title":"Antibiotics and pregnancy.","volume":"60","author":"S\u00e1 del Fiol","year":"2005","journal-title":"Die Pharmazie"},{"key":"R19-20260108","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/ajmg.a.35438","article-title":"Antiepileptic drugs and pregnancy outcomes.","volume":"158A","author":"Wlodarczyk","year":"2012","journal-title":"Am J Med Genet A"},{"key":"R20-20260108","first-page":"64","article-title":"Assessment of medicalization of pregnancy and childbirth in low-risk pregnancies: a cross-sectional study.","volume":"10","author":"Sabetghadam","year":"2022","journal-title":"Int J Community Based Nurs Midwifery"},{"key":"R21-20260108","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/medicina55050212","article-title":"Physical activity and depressive disorders in pregnant women-a systematic review.","volume":"55","author":"Ko\u0142oma\u0144ska","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"R22-20260108","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5811\/westjem.2018.1.35630","article-title":"Substance use in pregnant women using the emergency department: undertested and overlooked?","volume":"19","author":"Moyer","year":"2018","journal-title":"West J Emerg Med"},{"key":"R23-20260108","first-page":"1405","article-title":"Nausea and vomiting in early pregnancy.","volume":"2014","author":"Festin","year":"2014","journal-title":"BMJ Clin Evid"},{"key":"R24-20260108","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/bdra.20255","article-title":"Teratogen update: pseudoephedrine.","volume":"76","author":"Werler","year":"2006","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R25-20260108","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1378\/chest.119.2.466","article-title":"The safety of dextromethorphan in pregnancy: results of a controlled study.","volume":"119","author":"Einarson","year":"2001","journal-title":"Chest"},{"key":"R26-20260108","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13033-016-0070-x","article-title":"Predictors of alcohol and other drug use among pregnant women in a peri-urban South African setting.","volume":"10","author":"Onah","year":"2016","journal-title":"Int J Ment Health Syst"},{"key":"R27-20260108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejogrb.2023.08.375","article-title":"Use of opioids among pregnant women 1997-2016: a Danish drug utilization study.","volume":"289","author":"Rausgaard","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R28-20260108","first-page":"98","article-title":"Microbial aetiology of acute rhinosinusitis during pregnancy.","volume":"59","author":"Makinen","year":"2021","journal-title":"Rhinology"},{"key":"R29-20260108","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/phar.1649","article-title":"A review of antibiotic use in pregnancy.","volume":"35","author":"Bookstaver","year":"2015","journal-title":"Pharmacotherapy"},{"key":"R30-20260108","doi-asserted-by":"crossref","first-page":"e002321","DOI":"10.1136\/bmjdrc-2021-002321","article-title":"Effect of exposure to antibiotics on the gut microbiome and biochemical indexes of pregnant women.","volume":"9","author":"Su","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R31-20260108","doi-asserted-by":"crossref","first-page":"106189","DOI":"10.1016\/j.jinf.2024.106189","article-title":"Global prevalence of antibiotic consumption during pregnancy: a systematic review and meta-analysis.","volume":"89","author":"Orwa","year":"2024","journal-title":"J Infect"},{"key":"R32-20260108","doi-asserted-by":"crossref","first-page":"314","DOI":"10.15537\/smj.2023.44.3.20220762","article-title":"Predictors of antibiotic use in pregnant women attending Najran University Hospital, Saudi Arabia.","volume":"44","author":"Alshabi","year":"2023","journal-title":"Saudi Med J"},{"key":"R33-20260108","first-page":"687","article-title":"Treating the common cold during pregnancy.","volume":"54","author":"Erebara","year":"2008","journal-title":"Can Fam Physician"},{"key":"R34-20260108","doi-asserted-by":"crossref","first-page":"e053604","DOI":"10.1136\/bmjopen-2021-053604","article-title":"Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case\u2013control study.","volume":"11","author":"Cao","year":"2021","journal-title":"BMJ Open"},{"key":"R35-20260108","doi-asserted-by":"crossref","first-page":"100907","DOI":"10.1016\/j.ajogmf.2023.100907","article-title":"The use of Chinese herbal medicines throughout the pregnancy life course and their safety profiles: a population-based cohort study.","volume":"5","author":"Xiong","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R36-20260108","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1001\/jama.2022.19097","article-title":"Associations of unintended pregnancy with maternal and infant health outcomes: a systematic review and meta-analysis.","volume":"328","author":"Nelson","year":"2022","journal-title":"JAMA"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:01:00Z","timestamp":1767906060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041646","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}